tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Arvinas Inc

ARVN
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
8.230USD
+0.030+0.37%
์ข…๊ฐ€ย 07-29 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
530.84M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

์ฃผ์‹ ๋ณด์œ  ํ†ต๊ณ„

๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sun, May 10
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sun, May 10
์ฃผ์ฃผ
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
BlackRock Institutional Trust Company, N.A.
8.50%
Vanguard Portfolio Management, LLC
6.03%
D. E. Shaw & Co., L.P.
5.72%
Pfizer Inc
5.36%
Vanguard Capital Management, LLC
4.17%
๊ธฐํƒ€
70.23%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
BlackRock Institutional Trust Company, N.A.
8.50%
Vanguard Portfolio Management, LLC
6.03%
D. E. Shaw & Co., L.P.
5.72%
Pfizer Inc
5.36%
Vanguard Capital Management, LLC
4.17%
๊ธฐํƒ€
70.23%
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
๋น„์œจ
Investment Advisor
36.20%
Hedge Fund
25.48%
Investment Advisor/Hedge Fund
20.19%
Corporation
5.36%
Research Firm
2.56%
Venture Capital
2.50%
Individual Investor
2.47%
Pension Fund
0.55%
Bank and Trust
0.34%
๊ธฐํƒ€
4.35%

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Apr 1
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Apr 1
๋ณด๊ณ  ๊ธฐ๊ฐ„
๊ธฐ๊ด€ ์ˆ˜
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
2026Q1
522
53.93M
83.59%
-45.35M
2025Q4
513
61.93M
168.36%
-2.99M
2025Q3
525
64.92M
150.53%
-4.18M
2025Q2
518
67.55M
122.76%
+4.71M
2025Q1
504
63.19M
117.99%
-22.92M
2024Q4
484
75.18M
115.79%
+228.04K
2024Q3
476
75.20M
114.63%
+1.35M
2024Q2
469
73.21M
109.58%
+2.16M
2024Q1
476
70.86M
103.71%
+13.21K
2023Q4
483
66.87M
80.36%
+15.93M
๋” ๋ณด๊ธฐ

์ฃผ์ฃผ ํ™œ๋™

๎™Œ
์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
Chg %
๋‚ ์งœ
BlackRock Institutional Trust Company, N.A.
5.48M
8.57%
+310.94K
+6.01%
Dec 31, 2025
D. E. Shaw & Co., L.P.
3.69M
5.77%
+284.18K
+8.35%
Dec 31, 2025
Pfizer Inc
3.46M
5.41%
--
--
Dec 31, 2025
TCG Crossover Management, LLC
2.67M
4.17%
+1.05M
+64.85%
Dec 31, 2025
Point72 Asset Management, L.P.
2.32M
3.62%
+2.32M
--
Dec 31, 2025
State Street Investment Management (US)
1.84M
2.88%
-29.68K
-1.58%
Dec 31, 2025
Armistice Capital LLC
1.80M
2.81%
+600.00K
+50.00%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.62M
2.54%
-46.69K
-2.80%
Dec 31, 2025
๋” ๋ณด๊ธฐ

๊ด€๋ จ ETF

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
์ด๋ฆ„
๋น„์œจ
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.76%
State Street SPDR S&P Pharmaceuticals ETF
1.65%
Virtus LifeSci Biotech Clinical Trials ETF
0.91%
Invesco NASDAQ Future Gen 200 ETF
0.7%
iShares U.S. Pharmaceuticals ETF
0.28%
Federated Hermes MDT Small Cap Core ETF
0.24%
Zacks Small/Mid Cap ETF
0.22%
iShares Health Innovation Active ETF
0.16%
ProShares Ultra Nasdaq Biotechnology
0.11%
Invesco RAFI US 1500 Small-Mid ETF
0.1%
๋” ๋ณด๊ธฐ
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
๋น„์œจ1.76%
State Street SPDR S&P Pharmaceuticals ETF
๋น„์œจ1.65%
Virtus LifeSci Biotech Clinical Trials ETF
๋น„์œจ0.91%
Invesco NASDAQ Future Gen 200 ETF
๋น„์œจ0.7%
iShares U.S. Pharmaceuticals ETF
๋น„์œจ0.28%
Federated Hermes MDT Small Cap Core ETF
๋น„์œจ0.24%
Zacks Small/Mid Cap ETF
๋น„์œจ0.22%
iShares Health Innovation Active ETF
๋น„์œจ0.16%
ProShares Ultra Nasdaq Biotechnology
๋น„์œจ0.11%
Invesco RAFI US 1500 Small-Mid ETF
๋น„์œจ0.1%
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ